Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
about
Allergen injection immunotherapy for seasonal allergic rhinitisThe role of allergen exposure and avoidance in asthmaHow does the efficacy and safety of Oralair(®) compare to other products on the market?Immunological mechanisms of allergen-specific immunotherapyAllergic rhinitis: evidence for impact on asthmaROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammationAirway remodelling in asthma: from benchside to clinical practice.Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study.Conversion of Der p 23, a new major house dust mite allergen, into a hypoallergenic vaccine.Peptide immunotherapy for allergic disease.The IgE-facilitated allergen binding (FAB) assay: validation of a novel flow-cytometric based method for the detection of inhibitory antibody responses.Allergen immunotherapy in allergic respiratory diseases: from mechanisms to meta-analysesMechanisms of allergen specific immunotherapy--T-cell tolerance and more.Further marches: allergic and non-allergic.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.The efficacy assessment of a self-administered immunotherapy protocolAnalysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy.Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.Patient related outcomes in a real life prospective follow up study: Allergen immunotherapy increase quality of life and reduce sick days.Undertreatment of allergy: exploring the utility of sublingual immunotherapy.The link between allergic rhinitis and asthma: the united airways disease.Treatment options for the management of exercise-induced asthma and bronchoconstriction.Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.IgE-mediated cow's milk allergy in children.Immunotherapy preparation guidelines, rules, and regulation.Accelerated immunotherapy schedules.Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review.Cluster subcutaneous allergen specific immunotherapy for the treatment of allergic rhinitis: a systematic review and meta-analysis.Advances in asthma drug discovery: evaluating the potential of nasal cell sampling and beyond.Local IgE in non-allergic rhinitis.Efficacy and safety of sublingual immunotherapy in children.Grass pollen immunotherapy: where are we now.Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.New opportunities for allergen immunotherapy using synthetic peptide immuno-regulatory epitopes (SPIREs).Allergen-specific immunotherapy of allergy and asthma: current and future trends.Standardized allergen extracts: past, present and future.Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.Monophosphoryl lipid A (MPL) promotes allergen-induced immune deviation in favour of Th1 responses.The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study.Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium.
P2860
Q24243115-4C6F552A-4A78-4F53-A1A2-C7D7FC027DF4Q24612008-25D9C1A0-AD53-45B4-9A92-C335889DC435Q26745596-5F43A7FD-69DE-4BCF-98AC-17A8A07ADCC1Q28265326-1724D325-66DE-4398-A3A4-533F92280253Q33265228-4FF1B70B-9DD8-44B7-A977-AF6585EC0877Q33905772-4CF8EF45-97B7-46D2-A89D-01EC9B0434FCQ34105688-79D54019-FB40-4E68-BE55-FAD423511837Q34174366-19EB0486-93F9-4F42-B92A-37A962BAF919Q34415246-0A24A33F-D72D-4FB4-92FC-79C5BF018825Q35164800-7E3ECF76-47FC-4E13-8EEA-EC947B15A7C1Q35915934-DE06FEC1-B610-4BC0-8B6D-7194D25E3472Q36411170-C08606DC-80D2-4F23-AC5F-BF8186D1AA9AQ36515366-411D376D-F0CD-4A89-BF06-42B1767530E5Q36789966-E6BF6C32-9824-4D03-AD7A-1FF1CBCC9AC1Q36826600-8C2EF4FA-4C69-46B3-A263-260E706C9F76Q36881918-95C7F070-C3A0-4FCE-8400-40BB0FCB35D1Q36946146-AF56630E-C38B-40C1-B559-016103D8B9E7Q36966123-4C7D12B4-9C5C-4243-857D-C84AE9585C1FQ37355463-3D95E237-AF56-4235-B347-B4DEC4A56967Q37459337-CC91D2EF-5747-42D8-BCC6-869E9FE2B843Q37742100-0DC51D53-B6F3-4CC7-B18E-8C917DD3BC84Q37819748-69475941-8F64-4568-AC5A-5BBE071782C7Q37888684-98FCE645-5307-4F70-BCCD-30B8F8CDDB00Q38030874-616DE914-231B-46BF-BC3F-DF1B6A4B75C1Q38110730-F89D32F0-86A2-4388-A1A8-EB8E5C5FA968Q38111236-06F3F4DE-C182-43B4-9BD9-DF688CF573D2Q38119883-040CEBBA-0B6B-467D-9E27-83BB5514328FQ38184548-D0036DC5-772B-4AA5-A262-749C1A433289Q38205858-51F920F4-FDD4-471B-93DD-3FA8C93A23C0Q38286280-DAEBBD5A-9117-4092-AB0A-551B6F0158DAQ38615030-4A34356A-14B7-45C6-9D3F-A9547FB61FE9Q38773340-0866CE73-97B0-48B9-ACA1-C02BBFB4B3A2Q38792200-D3D4E79E-BCD6-4323-9888-51FE98E60A66Q38837264-25F7FCC9-856C-42BC-9699-6FBF1893DEC0Q40006542-7BBBC1F7-AE2E-4A17-B577-1DB8F0AE3870Q40377110-37A73D2F-DBC6-4EAA-9DAF-A81851B2EED7Q40476204-D0E7EF84-3ED1-416B-B3C9-4F642398722FQ40511372-21850332-9D0E-4410-8C58-8FE1CF59F7AAQ40586220-4DB5C4A9-CF3D-4C13-95EE-F01AABA36355Q40593688-513FA0FC-A766-42FB-9F3E-4C0D9291A7D7
P2860
Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Grass pollen immunotherapy for ...... randomized, controlled trial.
@en
type
label
Grass pollen immunotherapy for ...... randomized, controlled trial.
@en
prefLabel
Grass pollen immunotherapy for ...... randomized, controlled trial.
@en
P2093
P921
P356
P1476
Grass pollen immunotherapy for ...... randomized, controlled trial.
@en
P2093
P356
10.1067/MAI.2001.112027
P407
P577
2001-01-01T00:00:00Z